Lv5
810 积分 2022-02-11 加入
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
7天前
已完结
SARM1 signaling mechanisms in the injured nervous system
7天前
已完结
An update on factor XI structure and function
12天前
已完结
Therapeutic Potential of FXI Inhibitors: Hype or Hope?
12天前
已完结
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis
14天前
已完结
Are all the IL-23 blockers the same in inflammatory bowel disease?
15天前
已完结
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study
15天前
已完结
IBD disease-modifying therapies: insights from emerging therapeutics
16天前
已完结
Interleukin-23 p19 and Interleukin-12 p40, Head-to-Head, against Gut Inflammation
16天前
已完结
VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases
1个月前
已完结
皖公网安备34019202002308
